ELAN
Elanco Animal Health Incorporated
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$24.50
+0.35%Aug 26, 2026, 12:30 UTC
Elanco Animal Health completed a 25,000-square-foot expansion of its manufacturing facility in Elwood, Kansas, to boost monoclonal antibody production.
Source:Aug 24, 2026, 13:00 UTC
Keystone Cooperative, an Indiana-based agricultural cooperative, joined Alloy Partners' One Health Studio as an advisory partner and invested an undisclosed amount, aiming to develop agrifood offerings at the intersection of animal, plant, and human health.
Aug 7, 2026, 13:03 UTC
Elanco's new drug for New World screwworm received emergency approval from the FDA.
Aug 6, 2026, 21:58 UTC
On August 6, 2026, Elanco Animal Health Inc's shares fell 7.7% to $24.20, contributing to a weekly decline of 8.5%.
Source:Aug 5, 2026, 10:27 UTC
Elanco Animal Health reported second quarter 2026 revenue of $1,368 million, a 10% increase year-over-year, with reported net income of $54 million and adjusted EPS of $0.34.
Jun 18, 2026, 11:26 UTC
Elanco Animal Health Incorporated announced the launch of Elanco Ventures, a corporate venture capital platform, with a $25 million multi-year commitment to invest in animal health innovation.
Jun 15, 2026, 12:47 UTC
Elanco Animal Health Incorporated received USDA approval for TruCan Ultra Lyme-L4, the first and only 1/2 mL combination vaccine for Lyme and leptospirosis in dogs.
Source:Jun 4, 2026, 20:46 UTC
Elanco completed the acquisition of AHV, strengthening its commitment to the global dairy industry.
Source: